Stopping Ozempic Raises Cardiovascular Risk by 22 Percent
A VA study of 600,000 patients found that quitting GLP-1 drugs for two years erased all cardiovascular benefits and then some.
Nora Whitfield
Bureau: Chicago
The Wegovy Pill Has 400,000 Americans and Weight Loss Will Never Be the Same
Four hundred thousand Americans started taking the oral Wegovy in ten weeks, and a third of them had never used a GLP-1 drug before.
GLP-1 Drugs May Also Reduce Substance Use Disorders
A VA study of 600,000 veterans found GLP-1 users were 15 to 20 percent less likely to be diagnosed with substance use disorders.
Global Heating May Drive Half a Million Extra Premature Deaths by 2050
A Lancet study projects that rising temperatures will make people too hot to exercise, contributing to 520,000 additional premature deaths annually by 2050.
GLP-1 Drugs Are a Social Transformation Not Just a Medical One
One in seven American adults now takes or has taken a GLP-1 drug — and the behavioral, social, and identity shifts are outrunning the clinical data.